AIMEE JONES: Open Payments
NPI 1124109616 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 17 payments from 13 companies in 2025. Trend: 2023 $2,488 · 2024 $448 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 1 | $116 |
| Gilead Sciences, Inc. | 2 | $53 |
| Pharmacosmos Therapeutics Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Celgene Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Exelixis Inc. | 1 | $22 |
| SpringWorks Therapeutics, Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: XT CDX, ENHERTU, Trodelvy, MONOFERRIC, REBLOZYL, PLUVICTO, CABOMETYX, OGSIVEO.
Industry payments across NM — which companies pay providers there.
